StockNYSEEW
Edwards Lifesciences
$85.73
-0.27 (-0.31%)today
Valuation & earnings
- P/E ratio
- 51.03
- Forward P/E
- 25.39
- EPS (ttm)
- $1.68
- Forward EPS
- $3.38
- Price/book
- 4.66
- PEG ratio
- 1.85
- Payout ratio
- 0%
Financials (ttm)
- Revenue (ttm)
- 6.5B
- Revenue growth
- 13.6%
- Profit margin
- 15.43%
- Return on equity
- 9.18%
- Total cash
- 4.3B
- Total debt
- 704.4M
Earnings (EPS)
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Sep 30, 2025 | 0.59 | 0.67 | +12.63% |
| Dec 31, 2025 | 0.62 | 0.58 | -6.27% |
| Mar 31, 2026 | 0.73 | 0.78 | +7.33% |
| Jun 30, 2026 | 0.74 | 0.78 | +5.11% |
Next earnings date: Oct 29, 2026
Analyst view
Consensus ratingBuy29 analysts
Strong buy 4Buy 18Hold 7
12-month price targetsImplied upside: +17.77%
84
100.96
110
LowCurrent priceHigh
Latest news
(English)How Investors May Respond To Edwards Lifesciences (EW) Expanded TAVR Access And Transcatheter Valve Ambitions
Simply Wall St.Sep 18, 2026
Edwards Lifesciences (EW) Stock Looks Reasonable After Medicare TAVR Expansion
Simply Wall St.Sep 18, 2026
Edwards Lifesciences Sees TAVR Expansion, $2B TMTT Opportunity Ahead
MarketBeatSep 17, 2026
CMS expands TAVR Medicare coverage to asymptomatic patients
MedTech DiveSep 11, 2026
Is Edwards Lifesciences Stock Underperforming the Dow?
BarchartSep 8, 2026
Pacific Biosciences (PACB) Up 11.6% Since Last Earnings Report: Can It Continue?
ZacksSep 4, 2026
Related products
How visible is Edwards Lifesciences in AI search?
We ask AI search engines about Edwards Lifesciences and its market — live — and measure whether and how prominently the brand appears in their answers.
No AI visibility check has been run for Edwards Lifesciences yet.
Run a live check to see how AI search engines talk about this brand right now.
Is your brand this visible in AI search?
Aurora tracks your brand across 7 AI search engines — visibility, share of voice and the sources that shape AI answers.